Vitiligo-like lesions following imatinib mesylate therapy: a case series and review of literature

Vitiligo-like lesions following imatinib mesylate therapy: a case series and review of literature

Imatinib mesylate (IM), a tyrosine kinase inhibitor, has become a standard of care for the management of chronic myeloid leukemia. The safety profile of IM is favorable; however, few adverse effects such as gastrointestinal disturbances, fluid retention, skin rashes, and myelosuppression have been r...

Full description

Saved in:
Bibliographic Details
Main Authors: Neerja Saraswat, Shekhar Neema, Sushil Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Pigment International
Subjects:
imatinib mesylate
tyrosine kinase inhibitor
skin hypopigmentation
vitiligo-like lesions
Online Access:https://journals.lww.com/10.4103/pigmentinternational.pigmentinternational_52_21
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items